eClinical 솔루션 시장은 2024-2031년간 13.9%의 연평균 복합 성장률(CAGR)로 성장하여 2031년에는 233억 2,000만 달러에 달할 것으로 예상됩니다.
본 보고서는 철저한 2차 조사와 1차 조사, 시장 시나리오에 대한 상세한 분석을 바탕으로 주요 산업 촉진요인, 억제요인, 과제, 기회, 동향에 대해 논의합니다.
전자임상 솔루션 시장의 성장은 주로 헬스케어 및 생명과학 산업에서 생성되는 대량의 데이터, 임상시험 증가, 임상 연구 지원 노력, 의학 및 제약 연구 및 개발에 대한 자금 지원 증가에 의해 주도되고 있습니다. 또한, 대형 병원 체인의 IT 인프라 강화 노력과 정밀의료에 대한 수요 증가는 eClinical 솔루션 시장에서 활동하는 기업들에게 성장 기회를 제공할 것으로 예상됩니다.
(주* : SWOT 분석은 주요 5개사에 대해 기재)
eClinical Solutions Market Size, Share, Forecast, & Trends Analysis by Product (CDMS, CTMS, eCOA, ePRO, eDC, eTMF, Clinical Analytics, Safety Solutions), End User (Pharmaceutical, Clinical Research Organization, Medical Device), Phase - Global Forecast to 2031
The eClinical solutions market is expected to reach $23.32 billion by 2031, at a CAGR of 13.9% from 2024 to 2031.
Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends.
The growth of the eClinical solutions market is primarily driven by the large amounts of data generated by the healthcare & life sciences industries, the growing number of clinical trials, initiatives supporting clinical research, and increasing funding for medical & pharmaceutical research & development. Moreover, IT infrastructure strengthening initiatives by large hospital chains, and the rising demand for precision medicine are expected to generate growth opportunities for the players operating in the eClinical solutions market.
Based on product, the eClinical solutions market is segmented into clinical data management systems (CDMS), clinical trial management systems (CTMS), randomization & trial supply management systems, electronic data capture (EDC), electronic clinical outcome assessments (eCOA), electronic patient-reported outcomes (ePRO), clinical analytics platforms, electronic trial master file (ETMF), clinical data integration platforms, safety solutions, and other product types. In 2024, the CDMS segment is expected to account for the largest share of 28.3% of the eClinical solutions market. The large market share of this segment is attributed to the increasing need to sort and manage the huge amount of data generated during clinical trials to gain valuable insights, and the large number of clinical trials performed each year. For instance, in 2022, 12,337 clinical trials were conducted in the Western Pacific, 13,066 in Europe, 11,935 in the Americas, 11,030 in Southeast Asia, 4,593 in the Eastern Mediterranean, and 861 in Africa (Source: World Health Organization).
Based on clinical trial phase, the eClinical solutions market is segmented into Phase I, Phase II, Phase III, and Phase IV. The Phase IV segment is expected to register the highest CAGR during the forecast period 2024-2031. The growth of this segment is attributed to the increasing importance of post-market surveillance, the growing use of real-world data and real-world evidence for the post-market surveillance of drugs, the growing number of drug approvals, and increasing R&D investments from pharmaceutical and biopharmaceutical companies.
Based on end user, the eClinical solutions market is segmented into pharmaceutical & biopharmaceutical companies, clinical research organizations, medical device manufacturers, and other end users. The clinical research organizations segment is expected to register the highest CAGR during the forecast period. The segment's growth is driven by pharmaceutical & biopharmaceutical companies' increasing outsourcing to clinical research organizations and their rising focus on R&D activities for drug discovery and development and the adoption of advanced technologies among CROs for clinical trial management.
An in-depth analysis of the geographical scenario of the eClinical solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of the global eClinical solutions market in 2024, followed by Europe and Asia-Pacific. Among the U.S. and Canada included in North America, in 2024, the U.S. is expected to account for the largest share of the eClinical solutions market in North America. The large market share of the U.S. is attributed to the presence of clinical trial sponsors, the high adoption of digital solutions in the pharmaceutical industry, the large number of clinical trials conducted each year, and the high adoption of eClinical solutions ranging from data management systems to analytics due to stringent regulatory requirements set by the U.S. FDA.
Key companies operating in the global eClinical solutions market are Dassault Systems S.E. (France), Fountayn (U.S.), Merative L.P. (U.S.), eClinical Solutions LLC (U.S.), Clario (U.S.), eClinicalWorks, LLC (U.S.), IQVIA Inc. (U.S.), Parexel International (MA) Corporation (U.S.), MaxisIT Inc. (U.S.), Signant Health (U.S.), Castor (U.S.), Veeva Systems Inc. (U.S.), and Oracle Corporation (U.S.).
eClinical Solutions Market Assessment-by Product
(Note: Other product types include regulatory information management systems, electronic consent solutions, and institutional review board systems.)
eClinical Solutions Market Assessment-by Clinical Trial Phase
eClinical Solutions Market Assessment-by End User
(Note: Other end users include consulting companies, academic & research institutes, and hospitals.)
eClinical Solutions Market Assessment-by Geography
(Note*: SWOT analysis will be provided for the top 5 companies.)